News Image

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025

Provided By GlobeNewswire

Last update: Apr 7, 2025

CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that first quarter of fiscal year 2025 financial results will be reported after the market closes on Thursday, May 8th.

Read more at globenewswire.com

ORGANOGENESIS HOLDINGS INC

NASDAQ:ORGO (6/13/2025, 8:00:02 PM)

After market: 3.07 0 (0%)

3.07

-0.1 (-3.15%)



Find more stocks in the Stock Screener

Follow ChartMill for more